Приказ основних података о документу

dc.creatorStanković, Tijana
dc.creatorIlić, Tanja
dc.creatorPetković, Miloš
dc.creatorPantelić, Ivana
dc.creatorDobričić, Vladimir
dc.creatorCook, James M.
dc.creatorSavić, Miroslav
dc.creatorSavić, Snežana
dc.date.accessioned2024-03-29T08:04:50Z
dc.date.available2024-03-29T08:04:50Z
dc.date.issued2024
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5577
dc.description.abstractThe low aqueous and oil solubility of the novel pyrazoloquinolinone ligand (CW-02-79) with significant binding affinity for sigma-2 receptors in the brain hinders the development of conventional parenteral formulations and thus a comprehensive evaluation of its efficacy and safety. ...sr
dc.language.isoensr
dc.publisherInternational Society of Drug Delivery Sciences and Technology (APGI)sr
dc.publisherInternational Association for Pharmaceutical Technology (APV)sr
dc.publisherItalian Society of Technology and Legislation (S.T.E.L.F)sr
dc.relationinfo:eu-repo/grantAgreement/ScienceFundRS/Ideje/7749108/RS//sr
dc.relation.isreferencedbyhttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5578
dc.rightsrestrictedAccesssr
dc.source14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 18 - 21 March 2024, Vienna, Austriasr
dc.subjectCW-02-79sr
dc.subjectdrug-phospholipid complexsr
dc.subjectnanoemulsionsr
dc.subjectpyrazoloquinolinonesr
dc.titleOvercoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluationsr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.description.otherPoster presentation: [https://farfar.pharmacy.bg.ac.rs/handle/123456789/5578]sr
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_5577
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу